Yinying Lu

机构：Guiyang Medical University, Chinese PLA General Hospital, 302 Military Hospital of China · ORCID：0000-0002-7737-2334

发表论文 54 篇 · 总被引 638 次 · h-index 12

代表论文

• Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition) (2024 · Liver Research · 被引 18)
• NLRP6 deficiency enhances macrophage-mediated phagocytosis via E-Syt1 to inhibit hepatocellular carcinoma progression (2025 · Gut · 被引 8)
• Spotlight on NLRP6 and Tumor Research Situation: A Potential Cancer Participant (2023 · Journal of Immunology Research · 被引 6)
• Single-cell analysis uncovers liver susceptibility to pancreatic cancer metastasis via myeloid cell characterization (2024 · Discover Oncology · 被引 5)
• PJ‑001, a small‑molecule proteolysis‑targeting chimera, ameliorates atopic dermatitis‑like inflammation in mice by inhibiting the JAK2/STAT3 pathway and repairing the skin barrier (2024 · Experimental and Therapeutic Medicine · 被引 5)
• Prognostic impact of primary versus secondary resistance to sorafenib in patients with HCC (2025 · Therapeutic Advances in Medical Oncology · 被引 4)